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ABSTRACT
Objectives: Algorithms for mapping descriptive measures of
health status into preference-based measures are now widely
available and their application in economic evaluation is
increasingly commonplace. Existing algorithms make use of
scale, subscale, or item scores on descriptive measures. Item-
based algorithms entail fewer restrictions than their scale or
subscale-based equivalents but are subject to problems in
estimation and application. The objective of the present study
is to quantify any loss of predictive validity associated with
using subscale or scale scores (rather than item scores) to
derive conversion algorithms.
Methods: Multiple linear regression methods to derive
item-based, subscale-based, and scale-based algorithms for
mapping SF-36 data into Assessment of Quality of Life
(AQoL) utility scores in a stratiﬁed sample of persons aged
more than 16 years and resident in Victoria, Australia. The
theoretical consistency and predictive validity of competing
algorithms is evaluated against criteria reﬂecting the intended
use of predicted utility scores.
Results: Three mappings were suitable for between-group
comparisons. There was no discernible increase in error asso-
ciated with a move from the item-based mapping to either the
subscale- or scale-based mapping.
Conclusions: Our results do not support the hypothesis that
fewer restrictions on functional form necessarily result in a
lower magnitude of error when predicting between-group
differences. Rather, it appears that the subscale-based
mapping offers a good compromise—requiring fewer restric-
tions on the form of the relationship between SF-36 responses
and the AQoL utility score than the scale-based mapping and
permitting a more efﬁcient use of SF-36 data than the item-
based mapping.
Keywords: AQoL, priority setting, SF-36, transfer to utility.
Introduction
Many studies have estimated regression-based map-
pings from the SF-family instruments such as the
RAND-36 [1], SF-36 [2–4], or the SF-12 [5,6] to one
or more preference-based measure(s) of health-related
quality of life (HRQoL). For example, Fryback and
colleagues [7,8] estimated a regression-based mapping
from SF-36v1 subscales to the Quality of Well-Being
index in a noninstitutionalized US population aged
more than 45 years. Franks and colleagues estimated a
regression-based mapping from the SF-12’s physical
and mental component scores to the EQ5D in a sample
of 15,000 respondents drawn from the US general
population [9] and from the SF-12’s physical and
mental component scores to both the EQ5D and the
HUI3 in a much smaller sample of low income, mostly
African American or Hispanic adults aged more than
18 years [10]. Similarly, Nichol et al. [11] estimated
a regression-based mapping from SF-36v1 subscale
scores to the HUI2 in a sample of 6921 Kaiser Per-
manente members resident in Southern California.
Finally, Tsevat et al. [12] estimated a regression-based
mapping from the SF-36v1 subscales to the QWB
index in a sample of HIV+ patients with or without
symptomatic AIDs. Mortimer and Segal [13] provide a
full systematic review of regression-based mappings
between descriptive and preference-based measures.
Whereas preference-based measures derive a
summary utility score by weighting items and dimen-
sions of HRQoL according to the stated preferences of
the population, descriptive measures simply apply an
ad hoc or equal weighting to each item and each
dimension. Gold et al. [14] provides a more detailed
explanation of the differences between preference-
based and descriptive or non–preference-based mea-
sures of HRQoL (pp. 97–98). The use of regression-
based mappings is intended to circumvent data
problems by allowing predicted scores for preference-
based measures such as the Assessment of Quality of
Life (AQoL) instrument [15] or the EQ5D [16] to
proxy for directly observed AQoL or EQ5D scores
when—because of timing, lack of foresight or cost
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considerations—only descriptive measures of health
status are available. Regression-based mappings
discard the ad hoc or equal weighting of descriptive
measures and instead weight each item, subscale or
scale entering the regression according to the magni-
tude and direction of association with a preference-
based regressand. The development of a suitable
regression-based mapping provides a valuable tool for
researchers, permitting outcomes commonly used in
clinical trials such as the SF-36 to be transformed into
preference-based measures for the purposes of eco-
nomic evaluation. Although this constitutes a second-
best approach, it represents an extremely useful
technique in the absence of the widespread use of
preference-based measures in the conduct of clinical
trials.
Despite the proliferation of regression-based map-
pings in the literature, there has been relatively little
attention paid to a number of important methodologi-
cal questions in both the derivation and application of
such mappings. Moreover, the scant attention that has
been paid to these methodological questions has failed
to provide deﬁnitive answers. There are, for example,
questions surrounding the capacity of scale-based and
subscale-based algorithms to predict utility scores
given the implied restrictions on function form. Recall
that items typically receive either an ad hoc or equal
weighting when calculating subscale or dimension
scores for descriptive measures such that a subscale-
or scale-based regression has limited ﬂexibility to
reweight the information contained in descriptive
measures. Item-based algorithms should entail fewer
restrictions on the form of the relationship between the
information contained in descriptive measures and the
utility score but—as a result of degrees of freedom
constraints and collinearity problems—item-based
algorithms might incorporate less information than
subscale- or scale-based algorithms. The extent of any
deterioration in predictive validity associated with
using subscale or scale scores rather than item scores to
derive regression-based mappings is therefore in
doubt. This methodological question is of particular
interest because scale- or subscale-based algorithms
generally have wider application than item-based algo-
rithms because of the fact that group-level scale and
subscale scores are commonly available from pub-
lished studies.
The current article aims to provide empirical evi-
dence with respect to the last of these unanswered
methodological questions. In addressing this question,
this article compares item-based, subscale-based, and
scale-based algorithms for mapping SF36 health-status
data into AQoL utility scores. The theoretical consis-
tency and predictive validity of item-, subscale-, and
scale-based algorithms is then evaluated against crite-
ria reﬂecting the intended use of predicted AQoL
scores.
Methods
Data
Data were obtained from the Hawthorne, Richardson
and Day [17] validation study of the AQoL instrument.
The survey sample included 996 persons drawn from
three strata and comprised: 1) 396 noninstitutionalized
persons aged more than 16 years and resident in Victo-
ria during 1998; 2) 334 outpatients attending outpa-
tient clinics located at two Group A public hospitals in
metropolitan Melbourne during 1998; and 3) 266
admitted inpatients at nominated wards in three Group
A public hospitals in metropolitan Melbourne during
1998. The method of sampling differed between strata:
1) residences in the community strata were randomly
selected by address from the White Pages telephone
directory and the personwith the closest birthday to the
call date from each residence was selected into the
survey sample; 2) subjects in the outpatient strata were
randomly selected by time of consultation within
selected time frames; and 3) subjects in the inpatient
sample were purposefully selected from each nomi-
natedward based on severity of condition. As a result of
missing data, scores for the SF-36 and AQoL could be
derived for 902 of the 996 survey respondents. Missing
data were not imputed because introduction of an
additional source of error (associated with the imputa-
tion method) has the potential to mask or dilute the
effect of using item-based rather than subscale- or scale-
based algorithms. Note that the main aim of the present
study was to address the methodological question
described above and not to derive of a conversion
algorithm suitable for use in a particular target popu-
lation. Table 1 describes the demographic characteris-
tics of the 902 included cases and the 94 excluded cases.
Measures
The AQoL describes utility from a “handicap” perspec-
tive. The AQoL questionnaire has 15 items of which 12
are used in computing the utility index [15,17]. Each
item has four levels. There are ﬁve dimensions: Illness
(not used in utility computation), Independent Living,
Social Relationships, Physical Senses and Psychological
Well-Being. A multiplicative model is used to compute
the utility index wherein interactions between HRQoL
dimensions are permitted and the assumption of addi-
tive utility independence is relaxed [17]. The upper
boundary is 1.00,which designates fullHRQoL equiva-
lent states, 0.00 designates death equivalent states,
negative scores designate states worse than death and
the lower boundary of -0.04 designates theAQoL’s “all
worst HRQoL state.”
The SF-36v1 [2–4] is a functional health-status
instrument, measuring eight health state subscales
(dimensions): Physical Functioning (PF), Role Physical
(RP), Bodily Pain (BP), General Health (GH), Vitality
(VI), Social Function (SF), Role Emotion (RE), and
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Mental Health (MH). These can be combined into two
key health-status measures—Physical Function (PCS
index) and Mental Health (the MCS index). The items
are weighted, and each of the eight dimensions is sepa-
rately scored, using simple rating scale techniques.
These dimension scores are then transformed such that
the data form scores on a 0–100 point scale. For com-
putation of the PCS andMCS scale scores, each dimen-
sion score is weighted in a three-step process to
produce a standardized t-score where the population
mean score is 50  10 [18].
Data Analysis
The study sample was randomly split into an estima-
tion set (N = 455) and a validation set (N = 447) to
allow “post-sample” but “within-context” tests of pre-
dictive validity. There was no signiﬁcant association
between assignment to estimation/validation sets
and either population/outpatient/inpatient status (c2 =
0.823, df = 2, P = 0.663), age-group (c2 = 7.126,
df = 12, P = 0.849), sex (c2 = 0.102, df = 1, P =
0.749), highest education level (c2 = 0.964, df = 3,
P = 0.810), marital status (c2 = 3.455, df = 3, P =
0.327), working status (c2 = 0.955, df = 7, P = 0.996),
country of birth (c2 = 1.668, df = 1, P = 0.197), or self-
rated health (c2 = 4.990, df = 7, P = 0.661).
Multiple linear regression methods were used to
estimate alternative speciﬁcations of item-based,
subscale-based, and scale-based algorithms. For the
item-based algorithm, AQoL utility scores were
Table 1 Characteristics of respondents
Strata Included N (%) Excluded N (%) Total N (%)
Community 384 (42.6) 12 (12.8) 396 (39.8)
Outpatient 294 (32.6) 40 (42.6) 334 (33.5)
Inpatient 224 (24.8) 42 (44.7) 266 (26.7)
Sex
Male 448 (49.7) 40 (42.6) 488 (49.0)
Female 452 (50.1) 36 (38.3) 488 (49.0)
Missing 2 (<0.1) 18 (19.1) 20 (2.0)
Age group (years)
15–19 13 (1.4) 0 (0.0) 13 (1.3)
20–29 100 (11.1) 2 (2.1) 102 (10.2)
30–39 156 (17.3) 4 (4.3) 160 (16.1)
40–49 165 (18.3) 11 (11.7) 176 (17.7)
50–59 144 (16.0) 12 (12.8) 156 (15.7)
60–69 131 (14.5) 15 (16.0) 146 (14.7)
70–79 135 (15.0) 28 (29.8) 163 (16.4)
80+ 50 (5.5) 4 (4.3) 54 (5.4)
Missing 8 (0.9) 18 (19.1) 26 (2.6)
Birthplace
Australia 671 (74.4) 60 (63.8) 731 (73.4)
Other 229 (25.4) 16 (14.0) 245 (24.6)
Missing 2 (0.2) 18 (19.1) 20 (2.0)
Education level
Primary 94 (10.4) 22 (23.0) 116 (11.6)
High 451 (50.0) 37 (39.4) 488 (49.0)
TAFE/Trade 122 (13.5) 5 (5.3) 127 (12.8)
University 211 (23.4) 5 (5.3) 216 (21.7)
Missing 24 (2.7) 25 (26.6) 49 (4.9)
Marital status
Married/de facto 529 (58.6) 52 (55.3) 581 (58.3)
Single 168 (18.6) 7 (7.4) 175 (17.6)
Widowed 105 (11.6) 11 (11.7) 116 (11.6)
Divorced/separated 98 (10.9) 7 (7.4) 105 (10.5)
Missing 2 (0.2) 17 (18.1) 19 (1.9)
Employment status
Full-time 289 (32.0) 11 (11.7) 300 (30.1)
Part-time 119 (13.2) 7 (7.4) 126 (12.7)
Home duties 31 (3.4) 0 (0.0) 31 (3.1)
Student 30 (3.3) 0 (0.0) 30 (3.0)
Retired 283 (31.4) 45 (47.9) 328 (32.9)
Unemployed/other 56 (6.2) 4 (4.3) 60 (6.0)
Missing 7 (0.8) 20 (21.3) 27 (2.7)
Self-rated health
Excellent 113 (12.5) 5 (5.3) 118 (11.8)
Very good 246 (27.3) 13 (13.8) 259 (26.0)
Good 239 (26.5) 13 (13.8) 252 (25.3)
Fair 154 (17.1) 20 (21.3) 174 (17.5)
Poor 85 (9.4) 16 (17.0) 101 (10.1)
Very poor 41 (4.5) 6 (6.4) 47 (4.7)
Extremely poor 21 (2.3) 3 (3.2) 24 (2.4)
Missing 3 (0.3) 18 (19.1) 21 (2.1)
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regressed onto the 36-item scores of the SF-36 using
ordinary least squares (OLS) regression. The inclusion
of second-order and interaction terms in the item-
based regression was not practical given degrees of
freedom constraints and the large number of ﬁrst-
order terms. First-order terms in the item-based model
were retained solely on the basis of their contribution
to the regression as evaluated by the probability of F
(enter P  0.05, remove P  0.10) and using both
stepwise and backward procedures.
For the subscale-base algorithm, AQoL utility
scores were regressed onto the eight subscale scores of
the SF-36, their interactions and second-order terms
using OLS regression. Some previous studies esti-
mating scale- or subscale-based algorithms retained
all ﬁrst-order terms for reasons of theoretical
consistency—irrespective of their individual contribu-
tions to the model [9]. Nevertheless, the eight SF36
subscales were highly collinear in the estimation
sample such that the omission of one or more subscales
from the subscale-based algorithm is entirely consis-
tent with theory. In response to collinearity problems,
some previous studies have omitted subscales or items
relating to general or overall health on the grounds
that they are a function of a number of component
subscales or items that relate to particular dimensions
of health status [19]. Although the GH subscale was
highly correlated with all other subscales in the esti-
mation sample (Pearson’s r  0.422, P < 0.000), col-
linearity was no less of a problem for the SF (Pearson’s
r  0.549, P < 0.000), BP (Pearson’s r  0.452,
P < 0.000), or VI (Pearson’s r  0.500, P < 0.000)
subscales. First-order, interaction and second-order
terms were therefore retained solely on the basis of
their contribution to the regression as evaluated by the
probability of F (enter P  0.05, remove P  0.10)
and using both stepwise and backward procedures.
For the scale-based algorithm, AQoL utility scores
were regressed onto the PCS and MCS compo-
nent summary scores of the SF36, interactions
(MCS ¥ PCS) and second-order terms (PCS ¥ PCS and
MCS ¥ MCS) using OLS regression. Some previous
studies estimating scale- or subscale-based algorithms
retained all ﬁrst-order terms for reasons of theoretical
consistency—irrespective of their individual contribu-
tions to the model [9]. The SF-36 scales were collinear
in the estimation sample (Pearson’s r = 0.169,
P < 0.000) but sufﬁciently orthogonal to follow prece-
dent and retain both ﬁrst-order terms for the scale-
based regression. Interaction and second-order terms
were retained if they made a signiﬁcant individual
contribution to the regression based on the probability
of F (enter P  0.05, remove P  0.10) using both
stepwise and backward procedures.
For item-, subscale-, and scale-based algorithms,
case-wise leverage values and distances were used to
identify any observations (outliers or otherwise) with
undue inﬂuence on the regressions. Regressions were
re-run after excluding any inﬂuential observations to
test the stability of parameter estimates. In an effort to
minimize collinearity problems identiﬁed in item-,
subscale-, and scale-based regressions, regressors were
standardized against their respective distributions in
the estimation sample before rerunning regressions on
z-scores. To correct for heteroscedasticity, OLS regres-
sions were rerun through the origin after weighting all
observations in proportion to the heteroscedastic vari-
ance of the residuals.
Following Harvey [20], the “correctness” of each
speciﬁcation was evaluated against the criteria of par-
simony, identiﬁability, goodness of ﬁt, theoretical con-
sistency, and predictive power. In the present context,
theoretical consistency is concerned with 1) obtaining
non-negative coefﬁcients on all items, subscales, and
scales (when coded so that higher item, subscale and
scale scores reﬂect higher levels of HRQoL); and 2)
restricting predicted AQoL scores to the -0.04 to 1.0
domain of the target construct. To the extent that
subscales and/or scales reﬂect orthogonal dimensions
of HRQoL and to the extent that the AQoL achieves
good coverage of the HRQoL domain, then we might
also expect all subscales and/or scales to make a sig-
niﬁcant contribution to the subscale- and/or scale-
based regression and to be individually signiﬁcant.
Nevertheless, to the extent that there is collinearity
between subscales and/or scales, some subscales and/or
scales might be redundant in explaining variation in
AQoL scores and the usual consequences of including
an irrelevant explanatory variable arise.
Evaluating the predictive validity of competing
algorithms is much more complex than evaluating
theoretical consistency but is (minimally) concerned
with: 1) strength of association between predicted and
observed AQoL scores in the validation sample at the
individual level; 2) deviation between predicted and
observed AQoL scores at the individual level in the
validation sample; and 3) deviation between predicted
and observed AQoL scores at the group level in the
validation sample. Each criterion provides an indica-
tion of predictive validity in a particular application.
With regards to 1), the higher the strength of asso-
ciation, the better the algorithm is able to predict
variation along the scale. Note, however, that “two
measures can be perfectly correlated but have poor
agreement” [21, p. 997]. We might be relatively con-
ﬁdent that a high score on the predicted AQoL scale
would be mirrored by a high score on the observed
AQoL scale but there is no guarantee that the two
scales are compressed between the same limits. With
regards to 2), a summary measure of the deviation
between predicted and observed scores at the indi-
vidual level such as the mean absolute difference
(MAD) indicates the average precision with which we
can predict an individual’s AQoL score. To calculate
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the MAD, simply take the absolute difference between
the predicted and observed score for each individual,
sum over all individuals and then divide through by the
total number of observations. Nevertheless, further
information is required with regards to what sort of
MAD constitutes an “important” difference if this test
is to be interpretable. Although a high degree of pre-
cision in predicting AQoL scores at the individual level
would imply a high level of precision with respect to
other criteria, such precision might not be necessary
for the sort of between-group comparisons that form
the basis for estimates of both treatment effects and
health-state utilities. Speciﬁcally, errors at the indi-
vidual level might not translate into errors at the group
level such that minimizing the deviation between pre-
dicted and observed AQoL utility scores at the group
level is all that is required. Although 3) is the most
relevant test of predictive validity in measuring group-
level treatment effects and health-state utilities, all
three criteria will be reported here.
Results
Table 2 provides descriptive statistics for all ﬁrst-order
terms based on the 455 cases in the estimation sample.
Table 3 summarizes model ﬁt and estimated coefﬁ-
cients for ﬁnal speciﬁcations of item-based, subscale-
based, and scale-based mappings. Table 4 summarizes
post-sample tests of theoretical consistency and predic-
tive validity for the ﬁnal item-, subscale-, and scale-
based mappings using data from the 447 cases in the
validation set. Model ﬁt, estimated coefﬁcients and
post-sample tests of theoretical consistency and predic-
tive validity for all regressions are available on request.
Item-Based Algorithm
The OLS item-based mapping produced predicted
AQoL scores marginally above the upper limit of the
-0.04 to 1.00 range of the AQoL scale in 12 cases from
the validation set. Although this is inconsistent with
theory, the observed errors at the upper end of the scale
were small and unlikely to cause problems for the
estimation of treatment effects or health-state utilities.
The comparison between mean predicted and mean
observed AQoL utility scores for community, outpa-
tient, and inpatient subsamples suggests that the predic-
tive validity of the OLS model was adequate for
between-group comparisons. Mean predicted AQoL
utility scores were not signiﬁcantly different from their
corresponding mean observed scores in outpatient
(t = -1.248, P = 0.214), inpatient (t = 1.477, P =
0.143) and overall (t = -0.527,P = 0.598) groups. Even
in the community group (t = -1.959, P = 0.052), the
difference between mean predicted and mean observed
scores was less than 0.021 (95% conﬁdence interval
[CI] 0.00–0.04)—a magnitude of error that is unlikely
to mask minimally important differences (MIDs) for
between-group or pre-post treatment effects [23].
To correct collinearity problems (eigenval-
ues  0.08 and condition indexes  11.08 for the last
seven predictors to enter the regression), the OLS
regression was rerun after converting observations on
the independent variables into z-scores (OLS-Z). The
OLS-Z mapping corrected collinearity problems
(eigenvalues  0.194, condition indexes  4.779) but
comparison between mean predicted and mean ob-
served AQoL utility scores for community, outpatient,
Table 2 Descriptive statistics for dependent and independent
variables
N Minimum Maximum Mean SD
AQoL utility scores 455 -0.04 1.00 0.64 0.29
SF-36 scales
PCS 455 6.72 63.65 41.89 12.90
MCS 455 2.07 72.77 47.08 12.03
SF-36 subscales
PF 455 0.00 100.00 66.82 31.64
RP 455 0.00 100.00 52.64 44.54
BP 455 0.00 100.00 61.79 30.05
GH 455 0.00 100.00 59.95 26.07
VI 455 0.00 100.00 54.85 24.52
SF 455 0.00 100.00 69.86 31.39
RE 455 0.00 100.00 68.72 41.22
MH 455 4.00 100.00 70.98 20.09
SF-36 items
SF01 455 1.00 5.00 2.90 1.15
SF02 455 1.00 5.00 3.06 1.06
SF03 447 1.00 3.00 1.74 0.79
SF04 451 1.00 3.00 2.27 0.80
SF05 452 1.00 3.00 2.40 0.77
SF06 453 1.00 3.00 2.14 0.82
SF07 451 1.00 3.00 2.46 0.75
SF08 452 1.00 3.00 2.30 0.78
SF09 451 1.00 3.00 2.27 0.84
SF10 453 1.00 3.00 2.44 0.80
SF11 452 1.00 3.00 2.62 0.67
SF12 454 1.00 3.00 2.72 0.59
SF13 453 1.00 2.00 1.57 0.50
SF14 453 1.00 2.00 1.49 0.50
SF15 453 1.00 2.00 1.53 0.50
SF16 455 1.00 2.00 1.52 0.50
SF17 454 1.00 2.00 1.70 0.46
SF18 454 1.00 2.00 1.63 0.48
SF19 455 1.00 2.00 1.73 0.45
SF20 455 1.00 5.00 2.18 1.35
SF21 455 1.00 6.00 2.91 1.51
SF22 452 1.00 5.00 2.31 1.35
SF23 455 1.00 6.00 3.29 1.46
SF24 451 1.00 6.00 4.76 1.32
SF25 454 1.00 6.00 5.20 1.15
SF26 454 1.00 6.00 3.17 1.44
SF27 452 1.00 6.00 3.60 1.55
SF28 454 1.00 6.00 4.57 1.23
SF29 455 1.00 6.00 4.12 1.39
SF30 455 1.00 6.00 2.60 1.23
SF31 455 1.00 6.00 3.75 1.35
SF32 452 1.00 5.00 3.77 1.32
SF33 453 1.00 5.00 3.88 1.27
SF34 454 1.00 5.00 2.64 1.36
SF35 454 1.00 5.00 3.36 1.28
SF36 455 1.00 5.00 2.94 1.41
AQoL,Assessment of Quality of Life; BP, Bodily Pain;GH,General Health;MCS,Mental
Component Summary Score;MH,Mental Health; PCS, Physical Component Summary
Score; PF, Physical Functioning; RE, Role Emotion; RP, Role Physical; SF, Social Function;
VI,Vitality.
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and inpatient subsamples suggested that the predictive
validity of the OLS-Z mapping was inadequate for
between-group comparisons. Mean predicted AQoL
utility scores were signiﬁcantly different from their
corresponding mean observed scores in the com-
munity (t = -4.090, P = 0.000), outpatient (t = -2.723,
P = 0.007), and overall (t = -3.078, P = 0.002) groups.
In the community group, the difference between mean
Table 3 Regression algorithms for converting SF-36 scores to AQoL scores
Model Predictor b SE t Signiﬁcance R2 Adjusted R2
Item-based
OLS (Constant) 0.4890 0.089 5.491 0.000 — —
SF20 -0.0559 0.009 -6.286 0.000 0.474 0.473
SF01 -0.0356 0.012 -3.071 0.002 0.595 0.593
SF12 0.0834 0.017 4.801 0.000 0.646 0.644
SF21 -0.0304 0.007 -4.450 0.000 0.665 0.662
SF35 0.0245 0.007 3.439 0.001 0.680 0.676
SF28 0.0226 0.009 2.499 0.013 0.690 0.686
SF07 0.0542 0.015 3.561 0.000 0.699 0.694
SF36 -0.0245 0.009 -2.594 0.010 0.704 0.698
SF19 -0.0555 0.022 -2.508 0.013 0.707 0.701
SF24 0.0181 0.008 2.353 0.019 0.711 0.704
Subscale-based
Restricted OLS (Constant) -0.1083 0.056 -1.948 0.052 — —
SF 0.0040 0.001 6.792 0.000 0.513 0.513
GH 0.0066 0.001 5.949 0.000 0.618 0.617
BP 0.0017 0.000 4.690 0.000 0.645 0.643
MH 0.0014 0.001 1.462 0.144 0.651 0.648
MH ¥ PF 6.17 ¥ 10-5 0.000 7.071 0.000 0.681 0.678
MH ¥GH -5.77 ¥ 10-5 0.000 -3.847 0.000 0.690 0.686
SF ¥ BP -3.32 ¥ 10-5 0.000 -3.806 0.000 0.700 0.695
Scale-based
OLS (Constant) -0.7218 0.080 -9.021 0.000 — —
PCS 0.0305 0.004 7.637 0.000 0.452 0.450
MCS 0.0108 0.001 15.873 0.000 0.640 0.638
PCS ¥ PCS -0.0002 0.000 -4.338 0.000 0.654 0.652
AQoL,Assessment of Quality of Life; BP, Bodily Pain;GH,General Health;MCS,Mental Component Summary Score;MH,Mental Health; PCS, Physical Component Summary Score;
PF, Physical Functioning; SF, Social Function.
Table 4 Postsample predictive validity of item-, subscale-, and scale-based algorithms*
Model Criteria Group N Minimum Maximum Mean SD
Observed AQoL Validation sample Community 198 0.06 1.00 0.816 0.18
Outpatient 146 -0.04 1.00 0.632 0.26
Inpatient 103 -0.04 1.00 0.473 0.29
Total 447 -0.04 1.00 0.677 0.27
Predicted AQoL Item-based (OLS) Community 197 0.08 1.01 0.795 0.15
Outpatient 138 0.00 0.99 0.610 0.21
Inpatient 96 -0.02 1.01 0.507 0.22
Total 431 -0.02 1.01 0.671 0.22
Subscale-based (OLS*) Community 198 0.04 0.98 0.794 0.15
Outpatient 146 -0.04 0.96 0.614 0.21
Inpatient 103 -0.11 0.97 0.490 0.23
Total 447 -0.11 0.98 0.665 0.23
Scale-based (OLS) Community 198 0.11 0.98 0.782 0.15
Outpatient 146 0.05 0.97 0.615 0.20
Inpatient 103 0.05 0.97 0.494 0.21
Total 447 0.04 0.98 0.661 0.22
Mean absolute
deviation (MAD)
Item-based (OLS) Community
Outpatient
197
138
0.00
0.00
0.50
0.52
0.098
0.140
0.09
0.11
Inpatient 96 0.00 0.76 0.183 0.14
Total 431 0.00 0.76 0.130 0.12
Subscale-based (OLS*) Community 198 0.00 0.50 0.091 0.09
Outpatient 146 0.00 0.48 0.136 0.11
Inpatient 103 0.00 0.71 0.169 0.14
Total 447 0.00 0.71 0.123 0.12
Scale-based (OLS) Community 198 0.00 0.50 0.094 0.09
Outpatient 146 0.00 0.51 0.142 0.11
Inpatient 103 0.00 0.66 0.171 0.14
Total 447 0.00 0.66 0.127 0.11
*All values for postsample tests of predictive validity relate to the validation sample.
AQoL,Assessment of Quality of Life; OLS, ordinary least squares.
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predicted and mean observed scores was 0.05 (95% CI
0.02–0.07)—a magnitude of error that could well
mask MIDs for between-group or pre-post treatment
effects.
To correct for heteroscedasticity, the regression was
re-run after weighting all observations by the absolute
value of standardized SF01 scores—denoted |Z-SF01|
with mean = 0.736, SD = 0.531 and weights ranging
from 0.11 to 1.66 (WLS-Z). The WLS-Z mapping
produced predicted AQoL scores marginally below the
lower limit of the -0.04 to 1.00 range of the AQoL
scale in just three cases—two of whom had an
observed AQoL score equal to the lower limit of the
scale. Nevertheless, comparison between mean pre-
dicted and mean observed AQoL utility scores for
community, outpatient and inpatient subsamples sug-
gested that the predictive validity of the WLS-Z
mapping was inadequate for between-group compari-
sons. Mean predicted AQoL utility scores were signiﬁ-
cantly different from their corresponding mean
observed scores in the community (t = -7.108, P =
0.000), outpatient (t = -3.741, P = 0.000), and overall
(t = -5.407, P = 0.000) groups but not in the inpa-
tient group (t = -0.213, P = 0.831). In the community
group, the difference between mean predicted and
mean observed scores was 0.08 (95% CI 0.06–
0.11)—a magnitude of error that would mask the MID
for the AQoL of 0.06 reported by Hawthorne and
Osborne [23].
For each of the models considered above, the
Durbin-Watson d statistic (d  1.519 < dL, a = 0.05,
k = 12 = 1.550) indicated the presence of positive ﬁrst-
order autocorrelation, suggesting that one or more
relevant variables may have been omitted from the
regression. Although it is possible that various socio-
demographic or health-status variables available in the
data set could account for systematic variation in the
residuals, our aim was to provide a “self-contained”
mapping that would permit SF36 scores to be con-
verted to AQoL utility scores without relying on addi-
tional data that may or may not be available in a
particular application. Importantly, the residuals did
not exhibit any systematic pattern (linear or otherwise)
when plotted against excluded SF36 items such that
omitted variable problems cannot be overcome by the
inclusion of additional items or second-order terms.
Although the theoretical consistency and predictive
validity of the OLS item-based mapping was adequate
for between-group comparisons, none of the item-
based mappings was suitable for prediction at the
individual level. Correlations between predicted
and observed AQoL utility scores for community
(0.692), outpatient (0.739), and inpatient
(0.514) groups, group MADs never lower than
0.098, and high proportions (48.1%) of absolute
deviations between predicted and observed scores in
excess of 0.10 suggest that the use of item-based map-
pings to predict individual scores would entail an
unacceptably high level of error.
Subscale-Based Algorithm
One ﬁrst-order term (PF) with an estimated coefﬁcient
lacking theoretical consistency and individual signiﬁ-
cance was excluded from the OLS subscale-based
regression. The restricted OLS model produced pre-
dicted AQoL scores marginally below the lower limit
of the -0.04 to 1.00 range of the AQoL scale in only
one case. Comparison between mean predicted and
mean observed AQoL utility scores for community,
outpatient and inpatient subsamples suggests that the
predictive validity of the restricted OLS model was
adequate for between-group comparisons. Mean pre-
dicted AQoL utility scores were not signiﬁcantly dif-
ferent from their corresponding mean observed scores
in the outpatient (t = -1.026, P = 0.307), inpatient
(t = 0.764, P = 0.447), and overall (t = -1.088, P =
0.277) groups. Even in the community group (t =
-2.057, P = 0.041), the difference between mean pre-
dicted and mean observed scores was less than 0.022
(95% CI 0.00–0.04). In contrast, correlations between
predicted and observed AQoL index scores for com-
munity (r = 0.713), outpatient (0.736) and inpatient
(0.661) groups, a MAD as high as 0.169 for the inpa-
tient group and a high proportion (43.6%) of absolute
deviations between predicted and observed scores in
excess of 0.10 and as high as 0.71 suggest that the
restricted OLS subscale-based mapping is not suitable
for prediction at individual level.
Attempts to overcome collinearity and heterosce-
dacticity problems in the restricted OLS model using
standardized data and weighted least squares (WLS)
methods were not successful and yielded predicted
AQoL scores lacking both theoretical consistency and
predictive validity. The restricted WLS mapping, for
example, produced a large number of predicted AQoL
scores substantially below the lower limit of the
-0.04–1.00 range of the AQoL scale in both the vali-
dation and estimation sets. Of 43 cases with predicted
AQoL scores below the lower limit of the AQoL scale
in the validation set, 39 were below the lower limit by
more than 0.10 and 32 were below the lower limit by
more than twice the full width of the AQoL scale. The
magnitude of error at the lower end of the scale is such
that use of the restricted WLS subscale-based mapping
is inappropriate for any purpose.
Scale-Based Algorithm
The OLS scale-based mapping met all criteria with
regards theoretical consistency, with positive coefﬁ-
cients on all ﬁrst-order terms and only one of the
predicted AQoL scores fell outside the -0.04 to 1.00
range in either estimation or validation sets. The com-
parison between mean predicted and mean observed
AQoL utility scores in the validation set for commu-
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nity, outpatient, and inpatient subsamples suggests
that the predictive validity of the OLS model was
adequate for between-group comparisons. Mean pre-
dicted AQoL utility scores were not signiﬁcantly dif-
ferent from their corresponding mean observed scores
in the outpatient (t = -1.055, P = 0.293), inpatient
(t = 1.015, P = 0.312), and overall (t = -1.563, P =
0.119) groups. Even in the community group (t =
-3.135, P = 0.002), the difference between mean pre-
dicted and mean observed scores was less than 0.034
(95% CI 0.01–0.06). In contrast, correlations between
predicted and observed AQoL utility scores for com-
munity (r = 0.727), outpatient (0.713), and inpatient
(0.657) groups, a MAD as high as 0.171 for the inpa-
tient group, and a high proportion (52.8%) of absolute
deviations between predicted and observed scores in
excess of 0.10 and as high as 0.66 suggested that the
use of the OLS scale-based mapping to predict indi-
vidual scores would entail an unacceptably high level
of error.
Standardized data, removal of inﬂuential observa-
tions, and weighted least squares methods were
employed in an attempt to remedy collinearity and
heteroscedasticity problems identiﬁed in the OLS
scale-based regression. Nevertheless, OLS-Z and WLS-
Z scale-based mappings fell well short of the OLS
scale-based mappings on all predictive validity metrics.
As with both item-based and subscale-based map-
pings, the Durbin-Watson d statistic (d < 1.469 <
dL, a = 0.05, k = 3 = 1.738) suggested that one or
more relevant variables may have been omitted from
each of the scale-based mappings such that a source of
systematic variation was appearing in the residuals
rather than in the regression. Note, however, that
residuals from the scale-based regressions did not
exhibit any systematic pattern (linear or otherwise)
when plotted against SF-36 scales such that omitted
variable problems could not be overcome by the addi-
tion of second- or higher-order terms.
Discussion and Conclusions
After evaluating the theoretical consistency and predic-
tive validity of the item-, subscale-, and scale-based
algorithms described above, none of the mappings can
be considered suitable for the purposes of predicting
individual scores. This is not surprising because neither
the SF-36 nor the AQoL was originally designed for
predicting individual scores (although both have
previously been used for this purpose). Attempts to
quantify the hypothesized loss of predictive validity
associated with using subscale- or scale-based rather
than item-based mappings are therefore based solely
on the relative accuracy of item-, subscale-, and scale-
based mappings in predicting between-group differ-
ences. The comparison between mean predicted and
mean observed AQoL utility scores for community,
outpatient, and inpatient subsamples reported above
suggests that the predictive validity of regression-based
mappings was adequate for between-group compari-
sons in only three cases: the OLS item-based mapping,
the restricted OLS subscale-based mapping, and the
OLS scale-based mapping.
Although the predictive validity of the OLS
regression-based mappings described above may be
acceptable for predicting between-group differences,
none of these mappings was free from speciﬁcation
error. Moreover, attempts to remedy speciﬁcation
errors usually resulted in quite spectacular losses in
predictive validity and/or theoretical consistency. This
is not surprising where speciﬁcation error can be attrib-
uted to omission of a relevant variable or to unobserved
heterogeneity in SF-36 responses. Although there was
certainly evidence to suggest that a source of systematic
variation was appearing in the residuals rather than
in the regression, uncontrolled variation in item-,
subscale-, and scale-based regressions could not be
controlled by the inclusion of additional SF-36 items,
subscales, or scales. Moreover, to the extent that the
coverage and sensitivity of the two instruments
diverges, uncontrolled variation is to some extent
unavoidable in a “self-contained” mapping that would
permit SF-36 scores to be converted to AQoL utility
scores without relying on additional data that may or
may not be available in a particular application.
The primary research question considered here was
to quantify any loss of predictive validity associated
with using subscale or scale scores (rather than item
scores) to derive conversion algorithms. Item-based
algorithms should entail fewer restrictions on the form
of the relationship between SF-36 responses and the
AQoL utility score such that item-based algorithms
might be expected to have better predictive validity
than either subscale-based or scale-based algorithms.
On the other hand, item-based algorithms might incor-
porate less information than subscale- or scale-based
algorithms as a result of degrees of freedom constraints
and collinearity problems. Note, in particular, that the
number of regressors that would be required to
capture variation along all relevant dimensions of
HRQoL is much higher for the item-based mapping
than for the scale- and subscale-based mappings. The
degrees of freedom constraints that we face when using
a small sample size are therefore much more likely to
cause problems for item-based than for scale- or
subscale-based mappings and the relative merits of
item-, subscale-, and scale-based mappings are likely to
vary depending on the sample size used in estimation.
Conversely, the predictive validity of regression-based
algorithms might be improved by ﬁrst reducing the
data into summary scales when sample size is small
relative to the number of regressors.
In the present study, there was no discernible
increase in the error between mean predicted and mean
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observed associated with a move from the item-based
mapping to the scale-based mapping: community
(0.021 vs. 0.034), outpatient (0.022 vs. 0.017),
and inpatient (0.034 vs. 0.021). Likewise, the move
from the item-based mapping to the subscale-based
mapping was not associated with any additional error:
community (0.021 vs. 0.022), outpatient (0.022 vs.
0.018), and inpatient (0.034 vs. 0.017). Rather, it
appears that the subscale-based mapping offers a good
compromise—requiring fewer restrictions on the form
of the relationship between SF-36 responses and the
AQoL utility score than the scale-based mapping and
permitting a more efﬁcient use of SF-36 data than the
item-based mapping.
It should be emphasized that this conclusion may
not be generalizable to all mappings between descrip-
tive and preference-based measures of HRQoL. The
adequacy of a regression-based mapping depends on
the extent of outright errors that might be reﬂected in
the reliability of each measure (or lack thereof), any
between-instrument differences in the weights placed
on each dimension, and/or any between-instrument
differences with respect to coverage and sensitivity.
Each of these factors might be expected to vary when
generalizing from an SF-36 to AQoL mapping to a
mapping between the SF-12 and the EQ5D or
between a disease-speciﬁc outcome measure and the
HUI3. Note, for example, that transformation
between a disease-speciﬁc descriptive measure and
the HUI3 would require mapping from a detailed
description of a relatively narrow area of HRQoL
space to a general description of the entire HRQoL
domain. Moreover, the relative merits of item-,
subscale-, and scale-based mappings will clearly
depend on the extent to which the descriptive
measure under consideration aggregates over items
to obtain subscale and scale scores. Conﬁrmatory
studies of two sorts are therefore required. First, to
test whether the result reported above applies to
mappings from the SF-36 to other preference-based
measures such as the EQ5D and HUI3. Second, to
consider the relative merits of item-, subscale-, and
scale-based approaches when mapping from descrip-
tive measures other than the SF-36.
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